Nuri Karadurmus (Nuri Karadurmuş)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Advanced Non Small Cell Lung Cancer

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

Future oncology (London, England)

Cancer medicine

Balkan medical journal

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Saadettin Kılıçkap, Sertac Ak, Oldac U Dursun, Mehmet Ali Nahit Şendur, Nuri Karadurmus, Umut Demirci
Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events. Future oncology (London, England) (2023)
Irfan Cicin, Nuri Karadurmus, Ahmet Bilici, Taha Bahsi, Mehmet Ali Nahit Şendur, Umut Demirci, Sema Sezgin Goksu, Ozlem Er, Serdar Ceylaner, Ozge Fulya Ozturk Saglam, Birkan Aver, Saadettin Kılıçkap
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye. Future oncology (London, England) (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine 13 (1) (2023)
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kılıçkap
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer medicine (2023)
Ozan Yazıcı, Gokhan Ucar, Osman Sütçüoğlu, Nazım Serdar Turhal, Birol Yildiz, Michalis V Karamouzis, Sinan Yavuz, Nuri Karadurmus, Nurullah Zengin, Ravit Geva, Huseyin Abali
Metastatic colorectal cancer in both sides of Aegean sea: practice patterns and outcome. Current medical research and opinion 38 (4) (2022)
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Suleyman Sahin, Teoman Sakalar, Cihan Erol, Mehmet Ali Nahit Şendur, Ahmet Bilgehan Şahin, Erdem Cubukcu, Deniz Can Guven, Saadettin Kılıçkap, Yakup Ergün, Doğan Uncu, Nazım Serdar Turhal, Necdet Üskent, Havva Yeşil Çinkir, Atakan Demir, Ramazan Acar, Nuri Karadurmus, Sema Türker, Mustafa Altınbaş, Mert Karaoğlan, Filiz Çay Şenler
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. Journal of gastrointestinal cancer (2021)
Cengiz Karaçin, Tulay Eren, Esra Zeynelgil, Goksen İnanc İmamoglu, Mustafa Altınbaş, Ibrahim Karadag, Fatma Bugdayci Basal, Hasan Selçuk Özger, Osman Sütçüoğlu, Ozan Yazıcı, Nuriye Ozdemir, Ahmet Özet, Yeşim Yıldız, Selin Aktürk Esen, Gokhan Ucar, Doğan Uncu, Bedia Dinc, Musa Baris Aykan, İsmail Ertürk, Nuri Karadurmus, Burak Civelek, İsmail Çelik, Yakup Ergün, Mutlu Doğan, Ömür Berna Çakmak Öksüzoğlu
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future oncology (London, England) 17 (33) (2021)
Emre Yekedüz, İsmail Ertürk, Deniz Tural, Nuri Karadurmus, Serdar Karakaya, Mutlu Hizal, Rukiye Arıkan, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Ozlem Nuray Sever, Gokhan Ucar, Orçun Can, Mehmet Ali Nahit Şendur, Umut Demirci, Saadettin Kılıçkap, Irfan Cicin, Ömür Berna Çakmak Öksüzoğlu, Mustafa Özgüroğlu, Yuksel Urun
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Future oncology (London, England) 17 (35) (2021)
Osman Sütçüoğlu, Ayşegül İlhan, Seher Yildiz Tacar, Deniz Can Guven, Gokhan Ucar, Nuri Karadurmus, Fatih Yildiz, Emrah Eraslan, Doğan Uncu, Deniz Tural, Aytuğ Üner, Nazan Günel, Nuriye Ozdemir, Saadettin Kılıçkap, Ömür Berna Çakmak Öksüzoğlu, Ahmet Özet, Ozan Yazıcı
Thirty-day mortality rates after immunotherapy initiation. Immunotherapy 13 (17) (2021)
Atakan Demir, Nil Molinas Mandel, Semra Paydaş, Gökhan Demir, Ozlem Er, Nazım Serdar Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Saadettin Kılıçkap, Necdet Üskent, Nuri Karadurmus, Muhammet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez, Kadri Altundag, Seyda Gunduz, Meral Günaldı, Murat Sarı, Ismail Beypinar, Gül Başaran
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial Balkan medical journal 37 (2) (2020)